Amber Martin, APRN
Gerontology · San Antonio, TXNPI 1992440002
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $443 of the $610 with a category attached, or 72.6%. It is spread thinly across 9 manufacturers, the largest accounting for just 20.1%. Reporting peaked in 2022 at $407 and has fallen 56.6% since, to $177 in 2025.
Across 11 payments — averaging $55.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rigel Pharmaceuticals, Inc.$123
- Seagen Inc.$117
- Johnson & Johnson$113
- Incyte Corporation$100
- Beigene USA, Inc.$48
- Lilly USA, LLC$31
- plus $77 from 3 others
What the payments were for
- Food & beverage$44373%
- Education$16727%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 1 | $123 |
| Seagen Inc. | 1 | $117 |
| Johnson & Johnson | 3 | $113 |
| Incyte Corporation | 1 | $100 |
| Beigene USA, Inc. | 1 | $48 |
| Lilly USA, LLC | 1 | $31 |
| Amgen | 1 | $26 |
| AstraZeneca | 1 | $26 |
| Eisai Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$610 in reported general payments places this provider in the 55th percentile of 653 gerontology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 89 | $27,570 |
| GemtesaVibegron | 48 | $11,543 |
| MyrbetriqMirabegron | 32 | $7,672 |
| JanuviaSitagliptin Phosphate | 22 | $6,269 |
| NamzaricMemantine Hcl/Donepezil Hcl | 19 | $5,634 |
| TradjentaLinagliptin | 14 | $3,697 |
| EntrestoSacubitril/Valsartan | 12 | $3,456 |
| Clonidine | 22 | $3,052 |
| Potassium Chloride | 118 | $2,938 |
| Atorvastatin Calcium | 257 | $2,695 |
| Duloxetine Hcl | 88 | $2,069 |
| Divalproex Sodium | 124 | $1,862 |
| Mirtazapine | 108 | $1,792 |
| Memantine Hcl | 71 | $1,658 |
| Levothyroxine Sodium | 138 | $1,621 |
Paid to pharmacies, not to this prescriber.
Other gerontology in San Antonio
- Cecilia OrtizSan Antonio$13K
- Bianca LopezSan Antonio$11K
- Alexis SantangeloSan Antonio$9K
- Juliet GatobuSan Antonio$7K
- Ashlee DuggerSan Antonio$7K
- Amy RomickSan Antonio$5K
- Diana GarzaSan Antonio$4K
- Kimberly WelchCoppell$113K
- Tiffany KesslerDallas$84K
- Jennifer WestFort Worth$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.